Synageva BioPharma to Present at the Leerink Swann and Company Global Healthcare Conference 2013

Published: Feb 07, 2013

Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced its presentation at the upcoming Leerink Swann Global Healthcare Conference 2013.

Back to news